JP2020529431A - 細菌株を含む組成物 - Google Patents

細菌株を含む組成物 Download PDF

Info

Publication number
JP2020529431A
JP2020529431A JP2020505827A JP2020505827A JP2020529431A JP 2020529431 A JP2020529431 A JP 2020529431A JP 2020505827 A JP2020505827 A JP 2020505827A JP 2020505827 A JP2020505827 A JP 2020505827A JP 2020529431 A JP2020529431 A JP 2020529431A
Authority
JP
Japan
Prior art keywords
enterococcus
composition
bacterial strain
diversity
seq
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020505827A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020529431A5 (enExample
Inventor
イムケ エリザベス ムルダー
イムケ エリザベス ムルダー
セアニン マリー マククラスキー
セアニン マリー マククラスキー
ヘレン サヴィニャック
ヘレン サヴィニャック
イアン ジェフェリー
イアン ジェフェリー
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
4D Pharma Research Ltd
Original Assignee
4D Pharma Research Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB1712857.0A external-priority patent/GB201712857D0/en
Priority claimed from GBGB1800866.4A external-priority patent/GB201800866D0/en
Application filed by 4D Pharma Research Ltd filed Critical 4D Pharma Research Ltd
Publication of JP2020529431A publication Critical patent/JP2020529431A/ja
Publication of JP2020529431A5 publication Critical patent/JP2020529431A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4808—Preparations in capsules, e.g. of gelatin, of chocolate characterised by the form of the capsule or the structure of the filling; Capsules containing small tablets; Capsules with outer layer for immediate drug release
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/32—Foods, ingredients or supplements having a functional effect on health having an effect on the health of the digestive tract
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324—Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
JP2020505827A 2017-08-10 2018-08-10 細菌株を含む組成物 Pending JP2020529431A (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB1712857.0A GB201712857D0 (en) 2017-08-10 2017-08-10 Compositions comprising bacterial strains
GB1712857.0 2017-08-10
GB1800866.4 2018-01-19
GBGB1800866.4A GB201800866D0 (en) 2018-01-19 2018-01-19 Compositions comprising bacterial strains
EP18183642 2018-07-16
EP18183642.0 2018-07-16
PCT/EP2018/071831 WO2019030411A1 (en) 2017-08-10 2018-08-10 COMPOSITIONS COMPRISING BACTERIAL STRAINS

Publications (2)

Publication Number Publication Date
JP2020529431A true JP2020529431A (ja) 2020-10-08
JP2020529431A5 JP2020529431A5 (enExample) 2021-09-16

Family

ID=63524238

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020505827A Pending JP2020529431A (ja) 2017-08-10 2018-08-10 細菌株を含む組成物

Country Status (14)

Country Link
US (1) US20200237834A1 (enExample)
EP (1) EP3664824A1 (enExample)
JP (1) JP2020529431A (enExample)
KR (1) KR20200038970A (enExample)
CN (1) CN111246866A (enExample)
AU (1) AU2018312955A1 (enExample)
BR (1) BR112020002212A2 (enExample)
CA (1) CA3072013A1 (enExample)
IL (1) IL272491A (enExample)
MA (1) MA49982A (enExample)
MX (1) MX392976B (enExample)
SG (1) SG11202001174XA (enExample)
TW (1) TW201919674A (enExample)
WO (1) WO2019030411A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LT3768284T (lt) 2018-03-19 2022-04-11 4D Pharma Research Limited Enterecoccus flagelino kompozicijos, skirtos panaudoti terapijai
TWI731279B (zh) * 2018-11-21 2021-06-21 葡萄王生技股份有限公司 發酵乳桿菌gkf3、含其之組合物及改善精神失調之用途
KR102623834B1 (ko) * 2020-07-13 2024-01-12 서울대학교병원 에스트로겐을 포함하는 장내 미생물총 변화를 통한 남성의 대장암 예방 또는 치료용 조성물
AU2022348603A1 (en) * 2021-09-20 2024-02-29 Hudson Institute of Medical Research Biotherapeutic enterococcus isolates
CN117903980B (zh) * 2024-01-05 2024-10-18 四川大学 一种海氏肠球菌及其应用

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05252934A (ja) * 1991-04-08 1993-10-05 Quest Internatl Bv 親生物
JPH08259450A (ja) * 1995-03-17 1996-10-08 Nichinichi Seiyaku Kk インターフェロン産生増強剤
WO2017085520A1 (en) * 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains
WO2017085518A1 (en) * 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102010013209A1 (de) * 2010-03-29 2011-09-29 Technische Universität München Diarrhö-Prophylaktikum
EP2876167A1 (en) * 2013-11-21 2015-05-27 Institut Gustave Roussy Microbiota composition, as a marker of responsiveness to chemotherapy, and use of microbial modulators (pre-,pro- or synbiotics) for improving the efficacy of a cancer treatment

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH05252934A (ja) * 1991-04-08 1993-10-05 Quest Internatl Bv 親生物
JPH08259450A (ja) * 1995-03-17 1996-10-08 Nichinichi Seiyaku Kk インターフェロン産生増強剤
WO2017085520A1 (en) * 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains
WO2017085518A1 (en) * 2015-11-20 2017-05-26 4D Pharma Research Limited Compositions comprising bacterial strains

Also Published As

Publication number Publication date
IL272491A (en) 2020-03-31
CN111246866A (zh) 2020-06-05
BR112020002212A2 (pt) 2020-07-28
KR20200038970A (ko) 2020-04-14
MX2020001632A (es) 2022-06-08
US20200237834A1 (en) 2020-07-30
TW201919674A (zh) 2019-06-01
SG11202001174XA (en) 2020-03-30
MA49982A (fr) 2020-06-17
AU2018312955A1 (en) 2020-04-02
CA3072013A1 (en) 2019-02-14
WO2019030411A1 (en) 2019-02-14
EP3664824A1 (en) 2020-06-17
MX392976B (es) 2025-03-24

Similar Documents

Publication Publication Date Title
US10987387B2 (en) Compositions comprising bacterial strain
JP7054909B2 (ja) 細菌株を含む組成物
US10471108B2 (en) Compositions comprising bacterial strains
TWI749120B (zh) 包含細菌品系之組合物
JP6701276B2 (ja) 細菌株を含む組成物
JP2022058598A (ja) 細菌株を含む組成物
US20200237834A1 (en) Compositions comprising bacterial strains
OA20062A (en) Compositions comprising bacterial strains.
HK1254166B (zh) 包含细菌菌株的组合物
HK1260158B (en) Compositions comprising bacterial strains
OA18797A (en) Compositions comprising bacterial strains.

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20210805

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20210805

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20220525

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20220530

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20220829

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20230206